Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT06958081
Active, not recruiting Not applicable

tDCS and Musical Performance in Young Orchestra Musicians

NCT06958081 · tracked via the Priya Life Science Brazil tracker
Sponsor
Centro Universitário Augusto Motta
Phase
Not applicable
Started
2025-06-01
Last updated
2026-05-01

Condition(s) studied

Musical PerformanceNeuromodulationPerformance Anxiety

Investigational drug(s) / intervention(s)

Active transcranial direct current stimulation (tDCS)Sham transcranial direct current stimulation (tDCS)

Active transcranial direct current stimulation (tDCS): 2.0 mA anodal stimulation applied over FCz with cathode over Fp2 for 30 minutes using a transcranial direct current stimulation device.

Sham transcranial direct current stimulation (tDCS): Sham stimulation mimicking the sensations of tDCS; the current will be turned off after 30 seconds while maintaining electrode placement over FCz and Fp2.

Study summary

The goal of this clinical trial is to learn if transcranial direct current stimulation (tDCS) can improve the technical, expressive, and stage aspects of musical performance in young orchestra musicians aged 18 to 30 years. The main questions it aims to answer are:

* Does active tDCS improve musical performance compared to sham stimulation?
* Does active tDCS reduce music performance anxiety and increase musical self-efficacy? Researchers will compare the active tDCS group to the sham stimulation group to see if active stimulation has positive effects on musical performance and psychological factors.

Participants will:

* Receive either active or sham tDCS stimulation
* Perform a musical piece before and after stimulation
* Complete questionnaires about anxiety and musical self-confidence

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Musicians aged 18 to 30 years. * Minimum of 3 years of orchestral performance experience. * Active participation in a stable orchestra or ensemble. * No history of neurological or psychiatric disorders. * Not currently using psychotropic medications or recreational drugs. * Willingness to participate in all study sessions. * Signed informed consent form. Exclusion Criteria: * Presence of metallic implants in the head (e.g., cranial pins, aneurysm clips). * Presence of implanted electronic devices (e.g., pacemaker). * History of epilepsy or seizures. * Prior experience with transcranial direct current stimulation (tDCS). * Scalp dermatitis or lesions at the electrode placement sites. * Pregnancy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centro Universitário Augusto Motta (UNISUAM) Rio de Janeiro Rio de Janeiro

More Centro Universitário Augusto Motta trials in Brazil

Comparison Between Conventional Rehabilitation and Conventional Rehabilitation Through Dance in Patients With COPD Active, not recruiting
Cognitive Functional Therapy Compared With Pilates in Elderly Patients With Chronic Low Back Pain Recruiting
Rehabilitation of People With Post-tuberculosis Lung Disease Recruiting
Myofascial Release and 20-m Speed in Wheelchair Rugby Athletes With Spinal Cord Injury Starting soon
Prevalence of Pain in Mechanically Ventilated Patients in Intensive Care Units Recruiting

Other trials for the same condition

Safety and Acute Effects of tDCS on Musical Performance in Adolescent Musicians Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06958081 on ClinicalTrials.gov ↗ ← All trials in Brazil